LCPUFAs as Conditionally Essential Nutrients for Very Low Birth Weight and Low Birth Weight Infants : Metabolic, Functional, and Clinical Outcomes—How Much is Enough? - 28/05/14
, Ricardo Uauy, MD, PhD cRésumé |
Preterm infants are denied the rapid accumulation of docosahexaenoic acid (DHA) occurring during the third trimester in utero. The potential benefit of long-chain polyunsaturated fatty acids (LCPUFAs) has generated interest over the last 3 decades. Early intervention trials assessed the effects of supplementing infant formulas lacking DHA with concentrations equivalent to LCPUFA in milk of women from Westernized societies, leading to the inclusion of LCPUFA by the year 2000. Recently attention has been on determining the optimal dose of DHA and on whether there is in advantage in matching the higher doses of late pregnancy.
Le texte complet de cet article est disponible en PDF.Keywords : Preterm, Low birth weight infants, Very low birth weight infants, LCPUFA, Randomized controlled trials, Development
Plan
| Disclosures: M. Makrides receives honoraria (payable to her institution) for scientific advisory board contributions to Fonterra, Nestle Nutrition Institute, and Nutricia. |
|
| Associated honoraria for M. Makrides are used for professional development of students and early career researchers. |
Vol 41 - N° 2
P. 451-461 - juin 2014 Retour au numéro
Article précédent
- Donor Human Milk for Preterm Infants : What It Is, What It Can Do, and What Still Needs to Be Learned
- Tarah T. Colaizy
- Post-discharge Nutrition and the VLBW Infant: To Supplement or Not Supplement? : A Review of the Current Evidence
- Nneka I. Nzegwu, Richard A. Ehrenkranz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?